4//SEC Filing
Dexxon Holdings Ltd. 4
Accession 0001104659-22-117847
CIK 0001635088other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 8:40 AM ET
Size
8.3 KB
Accession
0001104659-22-117847
Insider Transaction Report
Form 4
Dexxon Holdings Ltd.
10% Owner
Transactions
- Purchase
Common Shares
2022-11-10$5.00/sh+4,000,000$20,000,000→ 102,849,443 total
Dexcel Pharma Technologies Ltd.
10% Owner
Transactions
- Purchase
Common Shares
2022-11-10$5.00/sh+4,000,000$20,000,000→ 102,849,443 total
Oren Dan
10% Owner
Transactions
- Purchase
Common Shares
2022-11-10$5.00/sh+4,000,000$20,000,000→ 102,849,443 total
Footnotes (2)
- [F1]Dexcel Pharma Technologies Ltd. ("Dexcel") is the direct beneficial holder of 4,684,130 common shares. Dexxon Holding Ltd. ("Dexxon") is the direct beneficial holder of 98,165,313 common shares. Dan Oren is the Executive Chairman of Dexcel and the sole director of Dexxon and is ultimately the sole shareholder of each entity.
- [F2]The common shares were purchased by Dexcel in a registered public offering on November 10, 2022.
Documents
Issuer
Roivant Sciences Ltd.
CIK 0001635088
Entity typeother
IncorporatedIsrael
Related Parties
1- filerCIK 0001636684
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 8:40 AM ET
- Size
- 8.3 KB